These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 19088325)
1. Osteonecrosis of the jaw and the use of antiangiogenic agents: just an association? Aragon-Ching JB; Dahut WL Oncologist; 2008 Dec; 13(12):1314; author reply 1315. PubMed ID: 19088325 [No Abstract] [Full Text] [Related]
2. Avascular osteonecrosis of the jaw as a side effect of bisphosphonate treatment. Bamias A; Terpos E; Dimopoulos MA Onkologie; 2010; 33(6):288-9. PubMed ID: 20523090 [No Abstract] [Full Text] [Related]
3. [Osteonecrosis of the jaw]. Eriksen EF Ugeskr Laeger; 2009 Feb; 171(8):629; author reply 629. PubMed ID: 19291862 [No Abstract] [Full Text] [Related]
4. Osteonecrosis of the jaw. Sykes DL Dent Today; 2007 Feb; 26(2):16. PubMed ID: 17348272 [No Abstract] [Full Text] [Related]
5. Jaw osteonecrosis related to bisphosphonates: a new concern for dentistry. Geist RY; Geist JR; Aksu M J Mich Dent Assoc; 2005 Nov; 87(11):40-2. PubMed ID: 16372547 [No Abstract] [Full Text] [Related]
6. Oral bisphosphonates and osteonecrosis of the jaw. Wynn RL Gen Dent; 2007; 55(1):8-10. PubMed ID: 17333956 [No Abstract] [Full Text] [Related]
7. Bisphosphonate treatment as a cause of jaw osteonecrosis. Kanat O; Ozet A; Ataergin S; Kuzhan O; Arpaci F; Ozturk B; Komurcu S; Ozturk M Oral Dis; 2007 May; 13(3):346-7. PubMed ID: 17448221 [No Abstract] [Full Text] [Related]
8. Diagnosis and Staging of Medication-Related Osteonecrosis of the Jaw. Ruggiero SL Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):479-87. PubMed ID: 26293329 [TBL] [Abstract][Full Text] [Related]
9. Bisphosphonates, hypercalcemia of malignancy, and osteonecrosis of the jaw. Wynn RL Gen Dent; 2005; 53(6):392-5. PubMed ID: 16366043 [No Abstract] [Full Text] [Related]
10. Osteonecrosis: what dentists need to know. Thoman RD Hawaii Dent J; 2006; 37(6):9-10, 12-3. PubMed ID: 17290948 [No Abstract] [Full Text] [Related]
11. [Bisphosphonates-associated osteonecrosis of the jaw: review on reported cases]. Gering A; Grange L; Villier C; Woeller A; Mallaret M Therapie; 2007; 62(1):49-54. PubMed ID: 17374348 [TBL] [Abstract][Full Text] [Related]
12. Osteonecrosis of the jaw associated with bisphosphonate therapy. Wirth SM; Lawson AP; Sutphin SD; Adams VR Orthopedics; 2009 Dec; 32(12):900. PubMed ID: 20000241 [No Abstract] [Full Text] [Related]
13. The science of bisphosphonate-related osteonecrosis of the jaws: the thin white line. Assael LA J Oral Maxillofac Surg; 2007 Jul; 65(7):1275-6. PubMed ID: 17577488 [No Abstract] [Full Text] [Related]
14. American Association of Oral and Maxillofacial Surgeons position paper: Bisphosphonate-Related Osteonecrosis of the Jaws-2009 update: the need to refine the BRONJ definition. Colella G; Campisi G; Fusco V J Oral Maxillofac Surg; 2009 Dec; 67(12):2698-9. PubMed ID: 19925998 [No Abstract] [Full Text] [Related]
16. Treating osteoporosis. Smith G; Stassen L; Flint S Ir Med J; 2009 Mar; 102(3):88; author reply 89. PubMed ID: 19489199 [No Abstract] [Full Text] [Related]
17. The tip of the iceberg. Felsenfeld AL J Calif Dent Assoc; 2005 Oct; 33(10):765-6. PubMed ID: 16350878 [No Abstract] [Full Text] [Related]
18. Low-down on link between bone-builders and jaw damage. Johns Hopkins Med Lett Health After 50; 2006 Sep; 18(7):1-2. PubMed ID: 17120363 [No Abstract] [Full Text] [Related]